You can follow the discussion on The WAGER, Vol 4(44) – Nalmefene: A Well-Tolerated Opioid Antagonist without having to leave a comment. Cool, huh? Just enter your email address in the form here below and you’re all set.
BASIS (The Brief Addiction Science Information Source)
